Role of MR-proADM and Monocyte CD169 in Predicting In-Hospital and 60-Day Mortality in COVID-19 Patients
Objectives: Mid-regional pro-adrenomedullin (MR-proADM) and monocyte CD169 (CD169) are valuable prognostic indicators of severe COVID-19. Methods: We assessed the predictive ability of a single measurement of MR-proADM and CD169 at emergency department (ED) admission to forecast in-hospital and 60-d...
Saved in:
| Main Authors: | Sergio Venturini, Daniele Orso, Francesco Cugini, Giovanni Del Fabro, Astrid Callegari, Ingrid Reffo, Danilo Villalta, Laura de Santi, Elisa Pontoni, Dina Giordani, Paolo Doretto, Chiara Pratesi, Maurizio Tonizzo, Gian Luca Colussi, Massimo Crapis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-12-01
|
| Series: | Clinical Pathology |
| Online Access: | https://doi.org/10.1177/2632010X241304958 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The association of midregional pro-adrenomedullin (MR-proADM) at ICU admission and fluid overload in patients post elective cardiac surgery
by: Carmen A. Pfortmueller, et al.
Published: (2024-09-01) -
Association of circulating MR-proADM with all-cause and cardiovascular mortality in the general population: Results from the KORA F4 cohort study.
by: Christina Gar, et al.
Published: (2022-01-01) -
ADME Properties in Drug Delivery
by: Luciana Scotti, et al.
Published: (2025-05-01) -
New modifications of ADM with applications in kind of PDEs
by: Eman Mohmmed Nemah, et al.
Published: (2025-12-01) -
High Risk Patient with ADM Breast Reconstruction
by: Teodor MARES, et al.
Published: (2024-08-01)